|
|
 |
Home |
 |
 |
Paul JohnsonLicAc, MBAcC, LicOHM, MRCHM, BA (Hons), PGCertLTHE, AHEAAcupuncturist - HerbalistBraefoot 1 Woodside Close Chiddingfold, Godalming Surrey GU8 4RH Tel: 01428 683 460 Mob: 07951 572 270 Email: pauljohnsonacupuncture@gmail.com
Paul is a member of the British Acupuncture Council and abides by a code of ethics which maintains high standards of education, discipline and practice. He is covered by full public indemnity and liability insurance.
In easy reach of Godalming, Haslemere and Farnham- bringing the wisdom of ancient China to modern England.
LATEST NEWS AND ARTICLES Iran Red Crescent Med J. 2012 Oct;14(10):631-40. Epub 2012 Oct 30. A randomized clinical trial of fibromyalgia treatment with acupuncture compared with fluoxetineAbstractBACKGROUND: To evaluate the effectiveness of acupuncture and compare it with fluoxetine in treatment of fibromyalgia syndrome (FMS). METHODS: We conducted a prospective, randomized clinical trial. Fifteen patients were treated with acupuncture and compared with a control group (n=15) of patients who received fluoxetine. Visual analogue scale, Fibromyalgia Impact Questionnaire (FIQ) and determined number of tender points were used as outcome measurements. RESULTS: After four weeks, the acupuncture group was significantly better than the control group in the number of tender points. Total fibromyalgia symptoms were significantly improved in the acupuncture group compared with the control group during the study period (P= 0.01). The largest difference in mean FIQ total scores was observed at 4 weeks (42.2 VS. 34.8 in the control and acupuncture groups, respectively; P= 0.007). At the end of one year of the follow up, patients who received acupuncture were significantly better than the control group in all measures. Fatigue and anxiety were the most significantly improved symptoms during the follow up period. DISCUSSION: Acupuncture significantly improved pain and symptoms of fibromyalgia. Also, we found that acupuncture did not have any side effect and was tolerable. SEE THE ORIGINAL AT: PubMed.gov
Current Opinion in Neurology: June 2013 - Volume 26 - Issue 3 - p 276–281 Medication-overuse headacheAbstractPurpose of review: Medication-overuse headache (MOH) is a well described clinical entity. There is a growing body of knowledge on the epidemiology of MOH, risk factors, and treatment strategies. Recent findings: The International Headache Society updated the classification criteria for MOH. Population-based studies provided an insight into the prevalence and peculiarities of MOH patients in eastern Europe and Asia. Large-scaled population-based longitudinal studies made it possible to analyze risk factors leading to the development of MOH. Imaging studies helped to better understand the pathophysiology of headache chronicity. New treatment strategies have been suggested. Summary: MOH is a common headache disorder and a serious public health problem all over the world. Although the treatment regimen for MOH patients is straightforward and the outcomes are favorable, it is time now to move forward and establish a predictive model for early recognition of patients at high risk, to intervene early and avoid development of chronic headache. SEE THE ORIGINAL AT: Current Opinion in Neurology
In easy reach of Godalming, Haslemere and Farnham- bringing the wisdom of ancient China to modern England. |
 |
 |
 |
 |
 |
|
 |